Eli Lilly and Company against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-10-09T20:00:02+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month LLY is +4.9% and MRNA +65.9%; over year to date LLY is +9.7% and MRNA +663.0%. The LLY/MRNA price ratio stands at 5.2412, below its 50-day average of 10.5198, and below the 200-day average of 18.5988. A ratio above its own average means LLY is gaining on MRNA; on this reading the recent edge belongs to MRNA.
| LLY | MRNA | |
|---|---|---|
| Price | $1179.27 | $225.00 |
| 1 day | +0.8% | +14.2%lead |
| 5 days | +3.2% | +18.4%lead |
| 1 month | +4.9% | +65.9%lead |
| 6 months | +23.5% | +338.8%lead |
| Year to date | +9.7% | +663.0%lead |
| 52-week position | 78% of range | 100% of range |
| 52-week range | $783.85–$1292.65 | $22.28–$225.00 |
| vs 50-day average | above $1173.97 | above $138.26 |
| vs 200-day average | above $1076.50 | above $72.63 |
| RSI (14) | 54 | 72 |
| Next earnings | 2026-10-29 | 2026-11-05 |
LLY trades at $1,179.27, above its 50-day average of $1,173.97, and above the 200-day at $1,076.50. It sits at 78% of its 52-week range ($783.85–$1,292.65); 14-day RSI is 54, in neutral territory; an average session moves it about 3.1%. For levels, the first level overhead is $1,200.00 (1.8% away) and the first support below is $1,173.97 (0.5% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
MRNA trades at $225.00, above its 50-day average of $138.26, and above the 200-day at $72.63. It sits at 100% of its 52-week range ($22.28–$225.00); 14-day RSI is 72, in overbought territory; an average session moves it about 7.1%. For levels, the first level overhead is $250.00 (11.1% away) and the first support below is $200.00 (11.1% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.1% against 3.1% for LLY, so an identical position size carries roughly 2.3× the daily risk.
The comparison turns on those levels: LLY clearing $1,200.00 or losing $1,173.97; MRNA clearing $250.00 or losing $200.00. Until one of them gives way, the relative reading above stands.